It wasDecember 31, 2019, when a cluster of patients was observed having pneumonia like symptoms and China informed the World Health Organization of anovel viralpneumoniain sea food market of Wuhan city, in Hubei Province. This pathogenic agent exhibited its high emerging ability and blowout all over the world in a very sort span of time. This newly emerging virus displayed influenza like symptoms along with severe chest pain and sore throat etc. The etiology of these infectionswas a novel coronavirus (2019-nCoV), possibly connectedto zoonotic or environmental exposure from the seafood market in Wuhan. Humantohuman transmission has accounted for most of the infections, including among health care workers.In this review we compared the clinical characteristic, management, outcomes, and infection control practices for patients infected with novel coronavirus (SARS-CoV-2).